Know Cancer

or
forgot password


N/A
N/A
N/A
Open (Enrolling)
Both
Carcinoma, Squamous Cell

Thank you

Trial Information


Inclusion Criteria:



- Patients with SCC of the head and neck

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

safety

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Nasser Al Rajhi, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

KFSH&RC

Authority:

United States: Institutional Review Board

Study ID:

RAC#0981-019

NCT ID:

NCT00534950

Start Date:

September 2007

Completion Date:

September 2015

Related Keywords:

  • Carcinoma, Squamous Cell
  • Randomized multicenter study of 5 vs 6 weekly fraction of RT in the treatment of SCC of the head and neck
  • Carcinoma
  • Carcinoma, Squamous Cell

Name

Location